• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例中期自然流产子宫破裂:米索前列醇阴道给药的并发症

A case of uterine rupture in mid-trimester spontaneous abortion: a complication of gemeprost vaginal administration.

作者信息

La Torre R, Bevilacqua E, D'Ambrosio V, Pasquali G, Aliberti C, Perrone G, Giancotti A

出版信息

Clin Exp Obstet Gynecol. 2014;41(5):599-600.

PMID:25864271
Abstract

The only prostaglandin analogue licensed in Italy for induction of labour in spontaneous and therapeutic abortion is gemeprost. The authors report a case of spontaneous uterine rupture of a scarred uterus, for previous caesarean sections, in a woman at 20 weeks of gestation with a diagnosis of spontaneous abortion. She received a pessary of gemeprost every three hours. After the fifth pessary, she complained of severe pain. At the ultrasound examination, uterine cavity appeared empty and the dead fetus was dislocated in the abdomen. Emergency laparotomy was performed and uterine tear was repaired. To induce labour for fetal demise or therapeutic abortion in second trimester in women with scarred uterus, the authors decided to lengthen the time between administrations of pessary from four to five hours depending on patient's symptoms. However the appropriate drug regimen has still to be found and more data are necessary.

摘要

在意大利,唯一被批准用于自然流产和治疗性流产引产的前列腺素类似物是吉美前列素。作者报告了一例有剖宫产史的瘢痕子宫孕妇,妊娠20周时诊断为自然流产,发生自发性子宫破裂的病例。她每三小时接受一次吉美前列素栓剂。在使用第五枚栓剂后,她诉说剧痛。超声检查显示子宫腔空虚,死胎位于腹腔。遂行急诊剖腹手术并修复子宫撕裂处。对于瘢痕子宫孕妇孕中期因胎儿死亡或治疗性流产而行引产时,作者决定根据患者症状将栓剂给药间隔时间从4小时延长至5小时。然而,仍需找到合适的药物方案,且需要更多数据。

相似文献

1
A case of uterine rupture in mid-trimester spontaneous abortion: a complication of gemeprost vaginal administration.一例中期自然流产子宫破裂:米索前列醇阴道给药的并发症
Clin Exp Obstet Gynecol. 2014;41(5):599-600.
2
Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case report.中期妊娠流产时子宫破裂。米索前列醇阴道栓剂和缩宫素的一种并发症。病例报告。
Br J Obstet Gynaecol. 1990 Nov;97(11):1061-2. doi: 10.1111/j.1471-0528.1990.tb02484.x.
3
A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.两种剂量米索前列醇联合米非司酮用于妊娠中期引产的随机研究。
Contraception. 1996 Aug;54(2):97-100. doi: 10.1016/0010-7824(96)00132-1.
4
Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion.米索前列醇与吉美前列素用于中期妊娠稽留流产引产的对比研究
Aust N Z J Obstet Gynaecol. 1997 Aug;37(3):331-4. doi: 10.1111/j.1479-828x.1997.tb02424.x.
5
Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.米非司酮联合吉美前列素用于早期妊娠流产引产
Acta Obstet Gynecol Scand. 1993 Jan;72(1):39-42. doi: 10.3109/00016349309013347.
6
Induction of second trimester abortion with mifepristone and gemeprost.米非司酮与吉美前列素用于中期妊娠引产
Br J Obstet Gynaecol. 1993 Aug;100(8):758-61. doi: 10.1111/j.1471-0528.1993.tb14269.x.
7
Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.米索前列醇阴道给药与吉美前列素阴道给药用于中期妊娠终止的比较:一项随机试验
Contraception. 1998 Oct;58(4):207-10. doi: 10.1016/s0010-7824(98)00099-7.
8
Intravaginal gemeprost and second-trimester pregnancy termination in the scarred uterus.阴道内给予吉美前列素与瘢痕子宫中期妊娠终止
Int J Gynaecol Obstet. 2007 Apr;97(1):35-9. doi: 10.1016/j.ijgo.2006.12.013. Epub 2007 Feb 22.
9
Misdiagnosis of interstitial pregnancy followed by uterine cornual rupture during induced midtrimester abortion.孕中期引产时间质部妊娠误诊继发子宫角部破裂
Acta Obstet Gynecol Scand. 1992 May;71(4):316-8. doi: 10.3109/00016349209021061.
10
An open study comparing two regimens of gemeprost for the termination of pregnancy in the second trimester.一项比较两种米索前列醇方案用于中期妊娠终止的开放性研究。
Acta Obstet Gynecol Scand. 1992 Apr;71(3):191-6. doi: 10.3109/00016349209009917.